AXIM Biotechnologies (AXIM) Stock Statistics & Valuation Metrics

AXIM Biotechnologies has a market cap or net worth of $3.45M. The enterprise value is $9.55M.

AXIM Biotechnologies has 355,625,760 shares outstanding. The number of shares has decreased by -2.65% in one year.

AXIM Biotechnologies’s return on equity (ROE) is 0.34 and return on invested capital (ROIC) is 54.46%.

The current PE Ratio of AXIM Biotechnologies is ―. AXIM Biotechnologies’s PEG ratio is 0.00250.

In the last 12 months, AXIM Biotechnologies had revenue of 70.46K and earned -3.51M in profits. Earnings per share was -0.01.

In the last 12 months, operating cash flow was -1.15M and capital expenditures 0.00, giving a free cash flow of -1.15M billion.

AXIM Biotechnologies pays an annual dividend of ―, resulting in a dividend yield of ―

AXIM Biotechnologies upcoming earnings date is ―, ―.

AXIM Biotechnologies as a current ratio of <0.01, with Debt / Equity ratio of -72.37%

In the past 12 months, AXIM Biotechnologies has paid 0.00 in taxes.

AXIM Biotechnologies EV to EBITDA ratio is -2.96, with an EV/FCF ratio of -8.45.

AXIM Biotechnologies has $2.80K in cash and marketable securities with $7.55M in debt, giving a net cash position of -$7.54M billion.

Gross margin is 0.00%, with operating margin of -2502.31%, and net profit margin of -4985.19%.

The average price target for AXIM Biotechnologies is ―, which is 11.43% higher than the current price. The consensus rating is ―